openPR Logo
Press release

OTC Consumer Health Products (Powder Form) Market Latest Trends and Forecast Analysis up to 2025

09-19-2017 09:51 AM CET | Health & Medicine

Press release from: TMR - Research Reports

OTC Consumer Health Products (Powder Form) Market Latest Trends

The TMR report observes that the major players of powder form OTC consumer health products have adopted the inorganic growth strategy to strengthen their position in the market. In addition to that, these market leaders are joining hands with local vendors in order to expand their presence in the rural areas of emerging economies to serve to the unmet needs of the population and stay ahead of the competition. Moreover, the unavailability of defined literature for the efficacy of these products is aiding to the research and development activities, and bodes well for the future of the players who invest on new and innovative products.

Geriatric Population Escalating Demand

Escalating percentage of geriatric population, growing awareness regarding lifestyle diseases, increase in self-medication, increase in switch from prescription to OTC products, and rise in disposable income are some of the key factors driving the demand in the global powdered form over the counter consumer health products market. Ubiquity of smartphones and widespread outreach of social media has significantly helped the global over the counter consumer health products market, imparting awareness at a rapid rate regarding the ill-effects of sedentary lifestyle of the urban population, which has escalated the need to add required vitamins and minerals to daily life along with fitness regime.

View and Download TOC of OTC Consumer Health Products (Powder Form) Market Research Report@ https://www.transparencymarketresearch.com/report-toc/29357

On the other hand, intense competition, adverse effects of supplements when taken without any physician’s guidance, lack of valid literature, and stringent regulations and guidelines are hindering the consumer health products market from attaining its true potential. Nevertheless, the current vendors of this market are expected to gain new revenue avenues from some of the emerging trends such as accelerated use of online resources, new product launches, aggressive market and promotion activities, and strategic alliances.

North America Most Lucrative Region

Based on indication, the report picks out nutritional supplements as most profitable segment of the global OTC consumer health products (powder form) market, serving considerably more demand than other segments, viz. skin care products, wound care management, oral care products, and gastrointestinal products. On the basis of distribution channel, the report expects independent pharmacies and retail stores segment to remain dominant throughout the forecast period, much ahead of other categories, viz. hospital pharmacy, hypermarkets and supermarkets, and online sales. Geographically, the developed region of North America currently serves the maximum demand, followed by Europe, whereas Asia Pacific is projected to increment the demand in the OTC consumer health products market at most robust CAGR during the forecast period.

Request and Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=29357

A recent market intelligence study by Transparency Market Research (TMR) has detected that the global over-the-counter (OTC) consumer health products (powder form) market is divided among a number of prominent players, facing significant competition from several local and domestic players. Some of the key companies identified by the report who currently hold substantial position in the global OTC consumer health products are: Sun Pharmaceuticals Ltd., Abbott Laboratories, GlaxosmithKline plc, Pfizer, Inc., Johnson & Johnson, Piramal Enterprises Ltd., Ipsen, Sanofi S.A., Bayer AG, American Health, and Glenmark Pharmaceuticals Ltd. The report projects the global OTC consumer health products (powder form) market to increment the demand at a CAGR of 3.6% during the forecast period of 2017 to 2025, reaching a valuation of US$40.6 bn by the end of 2025.

Buy Full OTC Consumer Health Products (Powder Form) Market Report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=29357<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OTC Consumer Health Products (Powder Form) Market Latest Trends and Forecast Analysis up to 2025 here

News-ID: 725248 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for OTC

Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
OTC Analgesics Market OTC analgesics market is projected to register a steady ex …
About OTC Analgesics Market The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Get Sample copy of this Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years.
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
ReportsWeb.com has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current